Ferrous Sulfate

Overview

Iron deficiency anemia is a large public health concern worldwide, especially in young children, infants, and women of childbearing age. This type of anemia occurs when iron intake, iron stores, and iron loss do not adequately support the formation of erythrocytes, also known as red blood cells. Ferrous sulfate is a synthetic agent used in the treatment of iron deficiency. It is the gold standard of oral iron therapy in the UK and many other countries.

Indication

抗贫血药。用于预防和治疗各种原因引起的缺铁性贫血，包括儿童或婴儿期需铁量增加而食物中供应不足、铁吸收障碍、妊娠中后期以及慢性失血等。

Associated Conditions

Anaemia folate deficiency
Anemia
Folate deficiency
Iron Deficiency (ID)
Iron Deficiency Anemia (IDA)
Hypochromic anemia

Clinical Trials

Title	Posted	Study ID	Phase	Status	Sponsor
Daily Iron vs Every-other-day Iron for Pediatric Patients With IDA	2024/08/13	NCT06550362	Phase 4	Not yet recruiting	Loma Linda University
Sucrosomial Iron and Iron Sulphate to Blood Donors	2023/01/10	NCT05678647	Not Applicable	Active, not recruiting	Uppsala University Hospital
An Open Study on the Efficacy of Iron Therapy Using iv Iron Relative to Oral Iron for Increasing LV Systolic Function	2022/04/04	NCT05309499	Not Applicable	Recruiting	Kazan State Medical University
Iron Supplementation and Neurodevelopmental Outcome in ELGANs	2020/12/31	NCT04691843	Phase 3	Completed	Ann & Robert H Lurie Children's Hospital of Chicago
Intravenous Iron Carboxymaltose, Isomaltoside and Oral Iron Sulphate for Postpartum Anemia	2019/05/21	NCT03957057	Phase 3	Completed	University Medical Centre Ljubljana
Ulipristal Use in Chinese Population	2016/07/07	NCT02825719	Phase 4	Terminated	Queen Mary Hospital, Hong Kong
Trial of Captafer® vs. Oral Iron Sulfate in the Treatment of Iron Deficiency Anemia in Patients With IBD	2016/05/17	NCT02774057	Phase 4	UNKNOWN	American University of Beirut Medical Center
Treatment of Iron Deficiency Anaemia in Inflammatory Bowel Disease With Ferrous Sulphate	2013/11/25	NCT01991314	Phase 4	Completed	Queen Mary University of London
IVICA: Intravenous Iron in Colorectal Cancer Associated Anaemia	2012/10/05	NCT01701310	Phase 4	Completed	Nottingham University Hospitals NHS Trust
Use of Iron Isomaltoside 1000 (Monofer) in Postpartum Anemia	2012/06/27	NCT01628770	Not Applicable	Completed	Dow University of Health Sciences

FDA Drug Approvals

Approved Product	Manufacturer	NDC Code	Route	Strength	Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product	Authorization Holder	Status	Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product	Manufacturer	Approval Number	Dosage Form	Strength	Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product	Company	Approval Number	Drug Type	Dosage Form	Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product	Registration No.	Company	Licence No.	Strength	Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product	ARTG ID	Sponsor	Registration Type	Status	Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product	Company	DIN	Dosage Form	Strength	Market Date
No Health Canada approvals found for this drug.

CIMA AEMPS Drug Approvals

Approved Product	Company	Registration Number	Pharmaceutical Form	Prescription Type	Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product	Company	License Number	Dosage Form	Strength	Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product	Company	Registration Number	Dosage Form	Strength	Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name	MA Holder	MA Number	Pharmaceutical Form	Active Ingredient	Authorization Date
No UK EMC drug information found for this drug.

AI-Powered Research

Premium Access